Methotrexate Prophylaxis

Methotrexate Prophylaxis is a pharmacological intervention involving the administration of methotrexate as a disease-modifying agent to prevent graft-versus-host disease in the context of hematopoietic stem cell transplantation.

386

Publications

26.3K

Citations

2.6K

Authors

801

Institutions

Publications per year

2017–2026

52

Authors

2.6K

  1. HJ
    H. Joachim Deeg

    Fred Hutch Cancer Center, United States

    19 publications · 3.5K citations

    17

    h-index

  2. RS
    Rainer Storb

    Fred Hutch Cancer Center, United States

    17 publications · 4.6K citations

    16

    h-index

  3. JH
    Joseph H. Antin

    Dana-Farber Cancer Institute, United States

    12 publications · 2.4K citations

    12

    h-index

  4. CA
    Claudio Anasetti

    Fred Hutch Cancer Center, United States

    11 publications · 2.1K citations

    11

    h-index

  5. CB
    CD Buckner

    Fred Hutch Cancer Center, United States

    11 publications · 2.4K citations

    11

    h-index

1–5 of 2.6K

Venues

  1. Blood

    32 publications · 3.4K citations

    26

    h-index

  2. PubMed

    Repository · 46 publications · 2.9K citations

    24

    h-index

  3. Cancer

    22 publications · 1.6K citations

    22

    h-index

  4. Journal of Clinical Oncology

    15 publications · 1.5K citations

    15

    h-index

  5. Biology of Blood and Marrow Transplantation

    TCT · 17 publications · 1K citations

    15

    h-index

1–5